| 1 |
34978016 | PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy. | 2022 Feb |
4 |
| 2 |
31604073 | Knockdown of PTEN decreases expression of estrogen receptor β and tamoxifen sensitivity of human breast cancer cells. | 2020 Jan |
4 |
| 3 |
33173749 | CD63+ Cancer-Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR-22. | 2020 Nov |
1 |
| 4 |
33318536 | Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells. | 2020 Dec 14 |
5 |
| 5 |
30573703 | The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy. | 2018 Dec 20 |
1 |
| 6 |
26418898 | Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells. | 2016 Mar 22 |
1 |
| 7 |
25882671 | Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion. | 2015 |
1 |
| 8 |
24853176 | MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases. | 2014 Jun 10 |
1 |
| 9 |
23515291 | Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor. | 2013 May |
1 |
| 10 |
22892847 | The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients. | 2012 Oct |
4 |
| 11 |
21170675 | Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells. | 2011 Nov |
2 |
| 12 |
21674849 | PTEN protein expression in postmenopausal steroid receptor positive early breast cancer patients treated with adjuvant tamoxifen. | 2011 Jan-Mar |
2 |
| 13 |
19435893 | Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer. | 2009 May 15 |
2 |
| 14 |
18500270 | Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen. | 2008 Aug |
2 |
| 15 |
18814240 | Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen. | 2008 Dec 15 |
1 |
| 16 |
17914589 | Apoptotic effects of signal transduction inhibitors on human tumor cells with different PTEN expression. | 2007 Nov |
1 |
| 17 |
15475931 | Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen. | 2005 Feb |
4 |
| 18 |
15589576 | Molecular genetic characterization of tamoxifen-associated endometrial cancer. | 2005 Jan |
1 |
| 19 |
12530022 | PTEN expression in tamoxifen-associated endometrial cancers. | 2002 Sep-Oct |
4 |